Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune‐Checkpoint Therapy Responses
Advanced Science · 2023-10 · 10 (28)
DOI: 10.1002/advs.202303183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.08.2023. Verfasst von Lea Miebach und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Thoracic, Vascular, and Visceral Surgery, Greifswald University Medical Center, 17475, Greifswald, Germany. Hauptthemen laut MEDLINE: Plasma Gases, Melanoma, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research (BMBF), Gerhard-Domagk-Foundation (Greifswald, Germany).
Abstract (Originalsprache)
Strategies to improve activity and selectivity are major goals in oncological drug development. Medical gas plasma therapy has been subject to intense research in dermatooncology recently. Based on partial gas ionization, this approach is exceptional in generating a variety of reactive oxygen species simultaneously that can be applied locally at the tumor side. It is hypothesized that combined gas plasma treatment can potentiate drug responses in the treatment of melanoma. Using a plasma jet approved as medical device in Europe, a systematic screening of 46 mitochondria‐targeted drugs identifies five agents synergizing in vitro and in vivo. Increased intratumoral leucocyte infiltration points to immunomodulatory aspects of the treatment, motivating to investigate responses to immune checkpoint blockade in combination with plasma. Tumor growth is monitored based on bioluminescent imaging, and single‐cell suspensions are retrieved from each tumor to characterize tumor‐infiltrating leucocytes using multicolor flow cytometry. Gene expression profiling is done using a validated NanoString panel targeting 770 genes specifically designed for immuno‐oncological research. Cell type abundancies are characterized from bulk RNA samples using the CIBERSORT computational framework. Collectively, the results indicate that local application of medical gas plasma technology synergizes with mitochondria‐targeted drugs and anti‐PD1 checkpoint therapy in treating melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General, Thoracic, Vascular, and Visceral Surgery, Greifswald University Medical Center, 17475, Greifswald, Germany.
- ZIK plasmatis , Leibniz Institute for Plasma Science and Technology (INP), 17489, Greifswald, Germany.
- Cancer Research Unit, Boehringer Ingelheim, Vienna, 1121, Austria.
- Department of Neurosurgery, Wien University Medical Center, Vienna, 1090, Austria.
- Laboratory of Molecular Pathology, State University of Londrina, Londrina, 86051-990, Brazil.
- Clinic for Dermatology and Venerology, Rostock University Medical Center, 18057, Rostock, Germany.
ORCID-Profile: Lea Miebach, Eric Freund, Ramona Clemen, Sander Bekeschus
Förderung
- German Federal Ministry of Education and Research (BMBF)
- Gerhard-Domagk-Foundation (Greifswald, Germany)
Zitieren
APA
Miebach, L., Melo-Zainzinger, G., Freund, E., Clemen, R., Cecchini, A. L., & Bekeschus, S. (2023). Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune‐Checkpoint Therapy Responses. Advanced Science, 10(28). https://doi.org/10.1002/advs.202303183
Vancouver
Miebach L, Melo-Zainzinger G, Freund E, Clemen R, Cecchini AL, Bekeschus S. Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune‐Checkpoint Therapy Responses. Advanced Science. 2023;10(28). doi:10.1002/advs.202303183
BibTeX
@article{Miebach2023,
author = {Miebach, Lea and Melo-Zainzinger, Gabriella and Freund, Eric and Clemen, Ramona and Cecchini, Alessandra Lourenco and Bekeschus, Sander},
title = {Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune‐Checkpoint Therapy Responses},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {28},
doi = {10.1002/advs.202303183}
}
EUVIMED